Risk of de novo Hepatocellular Carcinoma after HCV Treatment with Direct-Acting Antivirals

BACKGROUND AND AIMS: The aim of the study was to evaluate the risk of hepatocellular carcinoma (HCC) development after treatment with direct-acting antivirals (DAAs) and to compare HCC occurrence in these patients with that among patients treated with interferon (IFN)-based therapies. METHODS: We an...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Liver Cancer
Hlavní autoři: Finkelmeier, Fabian, Dultz, Georg, Peiffer, Kai-Henrik, Kronenberger, Bernd, Krauss, Franziska, Zeuzem, Stefan, Sarrazin, Christoph, Vermehren, Johannes, Waidmann, Oliver
Médium: Artigo
Jazyk:Inglês
Vydáno: S. Karger AG 2018
Témata:
Original Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5985411/
https://ncbi.nlm.nih.gov/pubmed/29888208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000486812
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky